Medtronic, NuVasive, InVivo Therapeutics & more: 6 device company notes

Written by Anuja Vaidya | September 01, 2017 | Print  |

Here are six key notes on orthopedic and spine device companies from the past week.

Medtronic will enter into the next phase of its strategic partnership with Mazor Robotics, making a third investment in the company.


Medtronic CEO Omar Ishrak received $15.7 million in compensation for the 2017 fiscal year.


InVivo Therapeutics eliminated 13 positions in a quest to focus attention on the Inspire Study and earn an FDA humanitarian device exemption for the Neuro-Spinal Scaffold.


NuVasive plans to expand its San Diego-based headquarters and add an innovation center to the facility.


MicroPort Orthopedics launched its Procotyl Prime Acetabular Cup System for hip replacement surgery.


Anika Therapeutics, a global orthopedic medicines company, elected Steven Chartier to vice president of regulatory and clinical affairs.


More articles on devices:
Spine implant segment leads global orthopedic device market: 6 observations
6 key quotes from CEO Omar Ishrak during Medtronic's Q1 earnings call
20 spine devices receive FDA 510(k) clearances in July

© Copyright ASC COMMUNICATIONS 2020. Interested in LINKING to or REPRINTING this content? View our policies here.

Featured Webinars

Featured Whitepapers